Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Synlife

Synlife

Synlife is an R&D biotech company exploring cell-free synthetic biology.

Co-founded by MIT scientists in 2017 and headquartered in Cambridge, MA, Synlife's team is developing therapeutic and diagnostic platforms through bottom-up engineering of synthetic cells. While much of synthetic biology relies on top-down engineering of extant living systems, this strategy is constrained by the fundamental drives of biology, such as evolutionary pressures and resource utilization for the necessary functions of life. By building synthetic minimal cells bottom-up, Synlife can reconstitute desirable functions of biology.

Timeline

2018
Synlife raises a $700,000 seed round.

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

References

Golden logo
By using this site, you agree to our Terms & Conditions.